ATCC and BioAgilytix Partnership

Introducing our synergistic partnership that combines ATCC’s expertise in cell line development, storage, management and distribution with BioAgilytix’s bioanalytical capabilities to advance the progress of innovative therapies for patients in need around the world.
  • Introducing our synergistic partnership that combines ATCC’s expertise in cell line development, manufacture, authentication, storage, management and distribution with BioAgilytix’s bioanalytical capabilities to advance the progress of innovative therapies for patients in need around the world.
  • We are combining our expertise to develop and deliver new and custom cell-based assay solutions to accelerate and enhance biopharmaceutical research and development.

Delivering Greater Value and Best-In-Class Services

BioAgilytix  logoBioAgilytix is a leading global bioanalytical testing laboratory specializing in large molecule bioanalysis. With advanced laboratories in USA and Europe, BioAgilytix provides premier immunogenicity, PK, biomarker, and cell-based assay services under GLP, GCP, and GMP to support all phases of biologics development, from discovery and preclinical to Phase I, II, III, and IV. BioAgilytix possesses particularly robust expertise developing new and custom cell-based assays for pre-screening/discovery, NAb analysis, drug potency and stability testing under GMP, and vaccines.

BioAgilytix brings complementary expertise and resources to ATCC, and in partnership, we are able to deliver a seamless solution for accessing, developing, manufacturing, characterizing, and storing cell lines, and developing, validating, and performing robust cell-based assays in which they will be used.

For more information on BioAgilytix’s science-driven capabilities, visit www.bioagilytix.com.